Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights
May 28 2015 - 02:04PM
Business Wire
Bristol-Myers Squibb Company (NYSE:BMY) will host a
teleconference on Monday, June 1, 2015, at 7 p.m.
EDT (6 p.m. CDT) to review data presented at the Annual
Meeting of the American Society of Clinical
Oncology (ASCO) in Chicago. Company executives will
provide an overview of data presented at the meeting, with a focus
on the company’s immuno-oncology portfolio, and address inquiries
from investors and analysts.
Investors and the general public are invited to listen to a live
webcast of the call at: http://investor.bms.com, by dialing
(647) 788-4901 or (877) 201-0168, confirmation code: 4580465.
Materials related to the call will be available at the same website
prior to the call. A replay of the call will be available beginning
at 10:30 p.m. EDT on June 1 through 11:59 p.m.
EDT on June 8. The replay can be accessed
at http://investor.bms.com or by dialing (855) 859-2056,
confirmation code: 4580465.
About Bristol-Myers
Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information, please visit www.bms.com or follow us on Twitter at
http://twitter.com/bmsnews.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150528006391/en/
Bristol-Myers SquibbMedia:Ken Dominski,
609-252-5251ken.dominski@bms.comorInvestors:Ranya Dajani,
609-252-5330ranya.dajani@bms.comorBill Szablewski,
609-252-5894william.szablewski@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Feb 2024 to Mar 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2023 to Mar 2024